BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the fourth quarter and full year 2025 before market open on Tuesday, March 3, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “.
BURLINGTON, Mass.--(BUSINESS WIRE)-- #chemicalID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces new capabilities for its handheld MX908 mass spectrometry device for trace chemical identification. These enhancements include an updated mission mode for hazardous vapor sampling and the addition of five priority drug targets, providing first responders with intelligence at the point of need for an informed, confident response. The MX908 mission mode.
Vaso (OTCMKTS:VASO - Get Free Report) and 908 Devices (NASDAQ: MASS - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations. Profitability This table compares Vaso and 908 Devices'
908 Devices (MASS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced preliminary unaudited financial results for the quarter and full year ended December 31, 2025. Preliminary unaudited revenue for the fourth quarter of 2025 is approximately $17.2 million, compared to $14.3 million in the fourth quarter of 2024, reflecting reported gro.
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2026) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") reports that ongoing field operations at its newly optioned Cerro Colorado Project in Sonora, Mexico, will significantly ramp up with field crews, drill crews and equipment mobilizing to the project preparation for its 1500 meters Phase I drill program. With environmental approvals in place and private property access agreement, current activities include rehabilitation of access routes, construction of drill pads, and site preparation required to support drilling.
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to provide an update on ongoing exploration and permitting activities at its Cerro Colorado Project, located in the State of Sonora, Mexico. Permitting Progress Masivo reports that it has submitted the required environmental permit applications to SEMARNAT (Secretaría de Medio Ambiente y Recursos Naturales) in support of its proposed exploration activities at the Cerro Colorado Project.
908 Devices Inc. ( MASS ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Barbara Russo - VP of Marketing & Corporate Communications Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Brendan Smith - TD Cowen, Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Ladies and gentlemen, thank you for joining us, and welcome to the 908 Devices Third Quarter 2025 Financial Results Conference Call.
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.23 per share a year ago.
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended September 30, 2025. “We are pleased with our year-to-date progress as we continue to build a more predictable and profitable business and bring our 908 Devices 2.0 vision to life,” said Kevin J. Knopp, CEO and Co-founder. “Revenue for the f.
